Posters

Efficacy of intravitreal aflibercept injection as a first line therapy in macular telengiectasia type 1

Poster Details

First Author: N.Kocak TURKEY

Co Author(s):    E. Beyazyildiz                             

Abstract Details



Purpose:

To report a patient with macular telangiectasia type 1 responsive to intravitreal aflibercept therapy as a first line treatment.

Setting:

Case report

Methods:

A 66 years old male patient who admitted to our clinic with a blurred vision in the right eye for 6 months. The patient did not present with any significant medical history apart from systemic hypertension. The patient was submitted to complete ophthalmological evaluation, fluorescein angiography (AF) and spectral domain optical coherence tomography (SD-OCT).

Results:

Visual acuity was 0.4 in the right eye and 1.0 in the left eye. Fundus fluorescein angiography showed a diffuse leakage. Optical coherence tomography showed intraretinal cysts and neurosensorial detachment. Ophthalmic examination of the patient showed type 1 macular telangiectasia (MACTEL) and as a first line therapy, two intravitreal aflibercept was applied with one month apart. Visual acuity was 0.7 and 1.0 and the thickness of the macula was 295 μm and 254 μm in the first and second visit respectively. At the 12 month visit, visual acuity was stable and sub-intraretinal fluid was not detected.

Conclusions:

Intravitreal aflibercept injection may be a satisfactory and successful therapy in the treatment of macular edema secondary to type 1 MACTEL.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy